Drug Sponsors

Amgen, LabCentral to support life sciences and biotech startups in Massachusetts

Monday, January 5, 2015 12:38 PM

Amgen has become a LabCentral platinum sponsor. LabCentral is an innovative, shared laboratory space designed as a launchpad for life sciences and biotech startups. As part of the sponsorship agreement, Amgen can nominate up to two promising life sciences and biotech startup companies per year to take up residence in LabCentral’s Kendall Square facilities, based in Cambridge, Mass.

More... »


Roche acquires Bina Technologies, enters genomic informatics market

Friday, December 19, 2014 01:00 PM

Roche has acquired Bina Technologies, a privately held company based in Redwood City, Calif. Bina provides a big data platform for centralized management and processing of next generation sequencing (NGS) data. Bina's proprietary on-market Genomic Management Solution, Bina-GMS, empowers basic, translational and academic researchers to perform fast and scalable analyses to maximize the value of genomic data.

More... »


Merck acquires OncoEthix, a privately-held oncology company

Friday, December 19, 2014 12:06 PM

Merck has acquired, through a subsidiary, OncoEthix, a Swiss-based, privately held biotechnology company specializing in oncology drug development. Merck has gained an investigational, novel oral BET (bromodomain) inhibitor, OTX015, currently in phase Ib studies for the treatment of hematological malignancies and advanced solid tumors.

More... »

NIH agency gets new name to reflect complementary, integrative health

Thursday, December 18, 2014 11:15 AM

The NIH agency with primary responsibility for research on promising health approaches already in use by the American public has a new name—the National Center for Complementary and Integrative Health (NCCIH).

More... »

Survey: France Biotech recommends policies to develop innovative life sciences companies

Thursday, December 18, 2014 11:09 AM

France Biotech, an association of entrepreneurs in the life sciences industry, has published the twelfth edition of its annual survey, Panorama of the Life Sciences Industry, which outlines the industry's major trends for 2013 and 2014 in France and worldwide. This year, 214 French companies took part in the study. France Biotech included multiple recommendations to foster excellence in the life sciences industry.

More... »

Takeda renames Millennium as Takeda Oncology

Wednesday, December 10, 2014 01:10 PM

Takeda Pharmaceutical has announced its global oncology business unit, headquartered in Cambridge, Mass., now will be called Takeda Oncology. The creation of Takeda Oncology will improve the company's ability to meet the unique and urgent needs of cancer patients, their loved ones and health care providers worldwide. Takeda will sustain its long-standing entrepreneurial approach to oncology R&D, while expanding its global commercial network and resources as Takeda Oncology.

More... »

Merck to acquire Cubist Pharmaceuticals for $9.5B to expand hospital acute care pipeline

Monday, December 8, 2014 03:29 PM

By Ronald Rosenberg
CenterWatch Staff Writer

Shying away from mega-mergers to instead focus on mid-sized drug makers that complement its product pipeline, Merck said this morning it will acquire Cubist Pharmaceuticals for $9.5 billion, including $1.1 billion in debt.

More... »

As GSK restructuring cuts 900 jobs in RTP, Parexel absorbs 450 of them in new business unit

Monday, December 8, 2014 01:30 PM

By Ronald Rosenberg
CenterWatch Staff Writer

GlaxoSmithKline’s global restructuring was felt sharply in North Carolina this week as it announced plans to cut 900 jobs in Research Triangle Park (RTP), where it has 2,500 employees and contractors working in research and development.

More... »

BTG acquires PneumRx for up to $475 million

Thursday, December 4, 2014 12:34 PM

London-based BTG will acquire PneumRx, a Mountain View, Calif.-based interventional pulmonology company in a deal worth up to $475 million, based on an initial consideration of $230 million and up to $245 million in performance-related milestone payments. BTG is an international specialist healthcare company active in interventional medicine and specialty pharmaceuticals. 

More... »

Otsuka to acquire Avanir for $3.5 billion

Tuesday, December 2, 2014 11:32 AM

Tokyo-based Otsuka Pharmaceutical will acquire Avanir Pharmaceuticals of Aliso Viejo, Calif., for $17 per share in cash, for a total value of approximately $3.5 billion.

More... »

CenterWatch
CWWeekly

January 26

2015 CRO outlook: M&As, IPOs, strategic partnerships and increased eClinical outsourcing expected to continue

IOM, industry stakeholders propose standards, guidelines for open sharing of clinical trial data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs